Endometrial expression of the estrogen-sensitive genes MMP-26 and TIMP-4 is altered by a substitution protocol without down-regulation in IVF patients

Human Reproduction

Volumn 21, Issue 12, 2006, Pages 3146-3156

  Pilka, R ^a,b   Oborna, I ^a   Lichnovsky, V ^a   Havelka, P ^a   Fingerova, H ^a   Eriksson, P ^c   Hansson, S ^b   Casslén, Bertil ^b,d  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d Biomedical Centre C 14   (Sweden)

Author keywords

Estrogen; Implantation; mRNA; Progesterone receptor; Regulation

Indexed keywords

ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 26; MESSENGER RNA; PROGESTERONE; PROGESTERONE RECEPTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 4; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DOWN REGULATION; DRUG SUBSTITUTION; ENDOMETRIUM; ENDOMETRIUM BIOPSY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLICULAR PHASE; GENE EXPRESSION; GENETIC VARIABILITY; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUTEAL PHASE; NIDATION; OVARY CYCLE; OVULATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TISSUE SECTION;

EID: 33751370625     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del180     Document Type: Article

References (83)

1. Apte SS, Olsen BR and Murphy G (1995) The gene structure of tissue inhibitor of metalloproteinases (TIMP) -3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem 270,14313-14318.
2. Arnett-Mansfield RL, DeFazio A, Mote PA and Clarke CL (2004) Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium. J Clin Endocrinol Metab 89,1429-1442.
3. Ben-Hur H, Mor G, Insler V, Blickstein I, Amir-Zaltsman Y and Kohen F (1995) Assessment of estrogen receptor distribution in human endometrium by direct immunofluorescence. Acta Obstet Gynecol Scand 74,97-102.
4. Bergeron C, Ferenczy A, Toft DO, Schneider W and Shyamala G (1988) Immunocytochemical study of progesterone receptors in the human endometrium during the menstrual cycle. Lab Invest 59,862-869.
5. Bischof P, Martelli M, Campana A, Itoh Y, Ogata Y and Nagase H (1995) Importance of matrix metalloproteinases in human trophoblast invasion. Early Pregnancy 1,263-269.
6. Brew K, Dinakarpandian D and Nagase H (2000) Tissue inhibitors of metalloproteinases: Evolution, structure and function. Biochim Biophys Acta 1477,267-283.
7. Budwit-Novotny DA, McCarty KS, Cox EB, Soper JT, Mutch DG, Creasman WT, Flowers JL and McCarty KS Jr (1986) Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res 46,5419-5425.
8. Chegini N, Rhoton-Vlasak A and Williams RS (2003) Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding. Fertil Steril 80,564-570.
9. Clark JH and Peck E Jr (1979) Female sex steroids receptors and function. Monogr Endocrinol 14,4-36.
10. de Coignac AB, Elson G, Delneste Y, Magistrelli G, Jeannin P, Aubry JP, Berthier O, Schmitt D, Bonnefoy JY and Gauchat JF (2000) Cloning of MMP-26. A novel matrilysin-like proteinase. Eur J Biochem 267,3323-3329.
11. Cox KH, DeLeon DV, Angerer LM and Angerer RC (1984) Detection of mRNA in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Dev Biol 101,485-502.
12. Droesch K, Navot D, Scott R, Kreiner D, Liu HC and Rosenwaks Z (1988) Transdermal estrogen replacement in ovarian failure for ovum donation. Fertil Steril 50,931-934.
13. Egeblad M and Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2,161-174.
14. Fielitz J, Leuschner M, Zurbrugg HR, Hannack B, Pregla R, Hetzer R and Regitz-Zagrosek V (2004) Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis. J Mol Med 82,809-820.
15. Garcia E, Bouchard P, De Brux J, Berdah J, Frydman R, Schaison G, Milgrom E and Perrot-Applanat M (1988) Use of immunocytochemistry of progesterone and estrogen receptors for endometrial dating. J Clin Endocrinol Metab 67,80-87.
16. Goffin F, Munaut C, Frankenne F, Perrier D'Hauterive S, Beliard A, Fridman V, Nervo P, Colige A and Foidart JM (2003) Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium. Biol Reprod 69,976-984.
17. Greene J, Wang M, Liu YE, Raymond LA, Rosen C and Shi YE (1996) Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 271,30375-30380.
18. Hampton AL and Salamonsen LA (1994) Expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation. J Endocrinol 141,R1-R3.
19. Isaka K, Nishi H, Nakai H, Nakada T, Feng Li Y, Ebihara Y and Takayama M (2003) Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma. Cancer 97,79-89.
20. Janne O, Kontula K, Luukkainen T and Vihko R (1975) Oestrogen-induced progesterone receptor in human uterus. J Steroid Biochem 6,501-509.
21. Jensen EV and DeSombre ER (1972) Mechanism of action of the female sex hormones. Annu Rev Biochem 41,203-230.
22. Jordan J, Craig K, Clifton DK and Soules MR (1994) Luteal phase defect: the sensitivity and specificity of diagnostic methods in common clinical use. Fertil Steril 62,54-62.
23. Kastner P, Bocquel MT, Turcotte B, Garnier JM, Horwitz KB, Chambon P and Gronemeyer H (1990a) Transient expression of human and chicken progesterone receptors does not support alternative translational initiation from a single mRNA as the mechanism generating two receptor isoforms. J Biol Chem 265,12163-12167.
24. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H and Chambon P (1990b) Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. Embo J 9,1603-1614.
25. Kokorine I, Marbaix E, Henriet P, Okada Y, Donnez J, Eeckhout Y and Courtoy PJ (1996) Focal cellular origin and regulation of interstitial collagenase (matrix metalloproteinase-1) are related to menstrual breakdown in the human endometrium. J Cell Sci 109 (8),2151-2160.
26. Leavitt WW, Chen TJ and Allen TC (1977) Regulation of progesterone receptor formation by estrogen action. Ann N Y Acad Sci 286,210-225.
27. Lecce G, Meduri G, Ancelin M, Bergeron C and Perrot-Applanat M (2001) Presence of estrogen receptor beta in the human endometrium through the cycle: Expression in glandular, stromal, and vascular cells. J Clin Endocrinol Metab 86,1379-1386.
28. Lelaidier C, de Ziegler D, Gaetano J, Hazout A, Fernandez H and Frydman R (1992) Controlled preparation of the endometrium with exogenous oestradiol and progesterone: A novel regimen not using a gonadotrophin-releasing hormone agonist. Hum Reprod 7,1353-1356.
29. Lessey BA, Killam AP, Metzger DA, Haney AF, Greene GL and McCarty KS Jr (1988) Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab 67,334-340.
30. Li H, Simon H, Bocan TM and Peterson JT (2000) MMP/TIMP expression in spontaneously hypertensive heart failure rats: The effect of ACE- and MMPinhibition. Cardiovasc Res 46,298-306.
31. Li W, Savinov AY, Rozanov DV, Golubkov VS, Hedayat H, Postnova TI, Golubkova NV, Linli Y, Krajewski S and Strongin AY (2004) Matrix metalloproteinase-26 is associated with estrogen-dependent malignancies and targets alpha1-antitrypsin serpin. Cancer Res 64,8657-8665.
32. Liu YE, Wang M, Greene J, Su J, Ullrich S, Li H, Sheng S, Alexander P, Sang QA and Shi YE (1997) Preparation and characterization of recombinant tissue inhibitor of metalloproteinase 4 (TIMP-4). J Biol Chem 272,20479-20483.
33. Lutjen P, Trounson A, Leeton J, Findlay J, Wood C and Renou P (1984) The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure. Nature 307,174-175.
34. Ma B, Zhu Z, Homer RJ, Gerard C, Strieter R and Elias JA (2004) The C10/ CCL6 chemokine and CCR1 play critical roles in the pathogenesis of IL-13-induced inflammation and remodeling. J Immunol 172,1872-1881.
35. Marbaix E, Kokorine I, Henriet P, Donnez J, Courtoy PJ and Eeckhout Y (1995) The expression of interstitial collagenase in human endometrium is controlled by progesterone and by oestradiol and is related to menstruation. Biochem J 305 (3),1027-1030.
36. Marchenko GN, Ratnikov BI, Rozanov DV, Godzik A, Deryugina EI and Strongin AY (2001) Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin. Biochem J 356,705-718.
37. Marchenko GN, Marchenko ND, Leng J and Strongin AY (2002) Promoter characterization of the novel human matrix metalloproteinase-26 gene: regulation by the T-cell factor-4 implies specific expression of the gene in cancer cells of epithelial origin. Biochem J 363,253-262.
38. Marchenko ND, Marchenko GN, Weinreb RN, Lindsey JD, Kyshtoobayeva A, Crawford HC and Strongin AY (2004) Beta-catenin regulates the gene of MMP-26, a novel metalloproteinase expressed both in carcinomas and normal epithelial cells. Int J Biochem Cell Biol 36,942-956.
39. Massai MR, Bergeron C, Martel D, de Ziegler D, Meduri G, Psychoyos A, Frydman R and Bouchard P (1993) Physiological oestradiol and progesterone replacement cycles in women with ovarian failure: A model to study endometrial maturation and sex steroid receptor regulation by exogenous hormones. Hum Reprod 8,1828-1834.
40. Mertens HJ, Heineman MJ, Theunissen PH, de Jong FH and Evers JL (2001) Androgen, estrogen and progesterone receptor expression in the human uterus during the menstrual cycle. Eur J Obstet Gynecol Reprod Biol 98,58-65.
41. Milgrom E and Baulieu EE (1970) Progesterone in uterus and plasma. I. Binding in rat uterus 105,000 g supernatant. Endocrinology 87,276-286.
42. Milgrom E, Thi L, Atger M and Baulieu EE (1973) Mechanisms regulating the concentration and the conformation of progesterone receptor (s) in the uterus. J Biol Chem 248,6366-6374.
43. Mote PA, Balleine RL, McGowan EM and Clarke CL (1999) Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle. J Clin Endocrinol Metab 84,2963-2971.
44. Mote PA, Johnston JF, Manninen T, Tuohimaa P and Clarke CL (2001) Detection of progesterone receptor forms A and B by immunohistochemical analysis. J Clin Pathol 54,624-630.
45. Navot D, Laufer N, Kopolovic J, Rabinowitz R, Birkenfeld A, Lewin A, Granat M, Margalioth EJ and Schenker JG (1986) Artificially induced endometrial cycles and establishment of pregnancies in the absence of ovaries. N Engl J Med 314,806-811.
46. Navot D, Anderson TL, Droesch K, Scott RT, Kreiner D and Rosenwaks Z (1989) Hormonal manipulation of endometrial maturation. J Clin Endocrinol Metab 68,801-807.
47. Nikas G, Drakakis P, Loutradis D, Mara-Skoufari C, Koumantakis E, Michalas S and Psychoyos A (1995) Uterine pinopodes as markers of the 'nidation window' in cycling women receiving exogenous oestradiol and progesterone. Hum Reprod 10,1208-1213.
48. Noyes RW, Hertig AT and Rock J (1950) Dating the endometrial biopsy. Fertil Steril 1,3-25.
49. Oborna I, Novotny R, Brezinova J, Petrova P, Lichnovsky V and Fingerova H (2004) Changes in the development of uterine pinopodes in steroid hormone supplemented cycles. Physiol Res 53,423-429.
50. Park HI, Ni J, Gerkema FE, Liu D, Belozerov VE and Sang QX (2000) Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor. J Biol Chem 275,20540-20544.
51. Paulson RJ, Sauer MV and Lobo RA (1997) Potential enhancement of endometrial receptivity in cycles using controlled ovarian hyperstimulation with antiprogestins: A hypothesis. Fertil Steril 67,321-325.
52. Pilka R, Whatling C, Domanski H, Hansson S, Eriksson P and Casslen B (2003) Epithelial expression of matrix metalloproteinase-26 (MMP-26) is elevated at midcycle in the human endometrium. Mol Hum Reprod 9,271-277.
53. Pilka R, Domanski H, Hansson S, Eriksson P and Casslen B (2004a) Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but downregulated in malignant tumours. Coordinated expression with MMP-26. Mol Hum Reprod 10,641-650.
54. Pilka R, Norata GD, Domanski H, Andersson C, Hansson S, Eriksson P and Casslen B (2004b) Matrix metalloproteinase-26 (matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer. Gynecol Oncol 94,661-670.
55. Press MF, Nousek-Goebl N, King WJ, Herbst AL and Greene GL (1984) Immunohistochemical assessment of estrogen receptor distribution in the human endometrium throughout the menstrual cycle. Lab Invest 51,495-503.
56. Press MF, Udove JA and Greene GL (1988) Progesterone receptor distribution in the human endometrium. Analysis using monoclonal antibodies to the human progesterone receptor. Am J Pathol 131,112-124.
57. Rahkonen OP, Koskivirta IM, Oksjoki SM, Jokinen E and Vuorio EI (2002) Characterization of the murine Timp4 gene, localization within intron 5 of the synapsin 2 gene and tissue distribution of the mRNA. Biochim Biophys Acta 1577,45-52.
58. Reimann I, Huth A, Thiele H and Thiele BJ (2002) Suppression of 15-lipoxygenase synthesis by hnRNP E1 is dependent on repetitive nature of LOX mRNA-3?-UTR control element DICE. J Mol Biol 315,965-974.
59. Rodgers WH, Osteen KG, Matrisian LM, Navre M, Giudice LC and Gorstein F (1993) Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. Am J Obstet Gynecol 168,253-260.
60. Rodgers WH, Matrisian LM, Giudice LC, Dsupin B, Cannon P, Svitek C, Gorstein F and Osteen KG (1994) Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest 94,946-953.
61. Rosenwaks Z (1987) Donor eggs: Their application in modern reproductive technologies. Fertil Steril 47,895-909.
62. Salamonsen LA (1999) Role of proteases in implantation. Rev Reprod 4,11-22.
63. Salamonsen LA, Butt AR, Hammond FR, Garcia S and Zhang J (1997) Production of endometrial matrix metalloproteinases, but not their tissue inhibitors, is modulated by progesterone withdrawal in an in vitro model for menstruation. J Clin Endocrinol Metab 82,1409-1415.
64. Sauer MV, Stein AL, Paulson RJ and Moyer DL (1991) Endometrial responses to various hormone replacement regimens in ovarian failure patients preparing for embryo donation. Int J Gynaecol Obstet 35,61-68.
65. Shi SR, Key ME and Kalra KL (1991) Antigen retrieval in formalin-fixed, paraffin- embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39,741-748.
66. Simon A, Hurwitz A, Pharhat M, Revel A, Zentner BS and Laufer N (1999) A flexible protocol for artificial preparation of the endometrium without prior gonadotropin-releasing hormone agonist suppression in women with functioning ovaries undergoing frozen-thawed embryo transfer cycles. Fertil Steril 71,609-613.
67. Snijders MP, de Goeij AF, Debets-Te Baerts MJ, Rousch MJ, Koudstaal J and Bosman FT (1992) Immunocytochemical analysis of oestrogen receptors and progesterone receptors in the human uterus throughout the menstrual cycle and after the menopause. J Reprod Fertil 94,363-371.
68. Steingold K, Stumpf P, Kreiner D, Liu HC, Navot D and Rosenwaks Z (1989) Estradiol and progesterone replacement regimens for the induction of endometrial receptivity. Fertil Steril 52,756-760.
69. Stetler-Stevenson WG, Krutzsch HC and Liotta LA (1989) Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 264,17374-17378.
70. Tseng L and Gurpide E (1975) Effects of progestins on estradiol receptor levels in human endometrium. J Clin Endocrinol Metab 41,402-404.
71. Tung L, Mohamed MK, Hoeffler JP, Takimoto GS and Horwitz KB (1993) Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Mol Endocrinol 7,1256-1265.
72. Tunuguntla R, Ripley D, Sang QX and Chegini N (2003) Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer. Gynecol Oncol 89,453-459.
73. Uria JA and Lopez-Otin C (2000) Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity. Cancer Res 60,4745-4751.
74. Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O'Malley BW and McDonnell DP (1993) Human progesterone receptor A form is a cell- and promoterspecific repressor of human progesterone receptor B function. Mol Endocrinol 7,1244-1255.
75. Welgus HG and Stricklin GP (1983) Human skin fibroblast collagenase inhibitor. Comparative studies in human connective tissues, serum, and amniotic fluid. J Biol Chem 258,12259-12264.
76. Wen DX, Xu YF, Mais DE, Goldman ME and McDonnell DP (1994) The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol Cell Biol 14,8356-8364.
77. Whitfield HJ, Brady LS, Smith MA, Mamalaki E, Fox RJ and Herkenham M (1990) Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: A detailed protocol. Cell Mol Neurobiol 10,145-157.
78. Young WS (1990) In situ hybridization histochemistry. In Björklund A, Hökfelt T, Wouterlood FG, van den Pol AN (eds) Handbook of Chemical Neuroanatomy: Analysis of Neuronal Microcircuits and Synaptic Interactions. Elsevier Science Publishers B.V., Amsterdam, pp. 481-512.
79. Young DA, Phillips BW, Lundy C, Nuttall RK, Hogan A, Schultz GA, Leco KJ, Clark IM and Edwards DR (2002) Identification of an initiator-like element essential for the expression of the tissue inhibitor of metalloproteinases-4 (Timp-4) gene. Biochem J 364,89-99.
80. Younis JS, Simon A and Laufer N (1996) Endometrial preparation: Lessons from oocyte donation. Fertil Steril 66,873-884.
81. Zhang J, Cao YJ, Zhao YG, Sang QX and Duan EK (2002) Expression of matrix metalloproteinase-26 and tissue inhibitor of metalloproteinase-4 in human normal cytotrophoblast cells and a choriocarcinoma cell line, JEG-3. Mol Hum Reprod 8,659-666.
82. de Ziegler D, Cornel C, Bergeron C, Hazout A, Bouchard P and Frydman R (1991) Controlled preparation of the endometrium with exogenous estradiol and progesterone in women having functioning ovaries. Fertil Steril 56,851-855.
83. de Ziegler D, Bergeron C, Cornel C, Medalie DA, Massai MR, Milgrom E, Frydman R and Bouchard P (1992) Effects of luteal estradiol on the secretory transformation of human endometrium and plasma gonadotropins. J Clin Endocrinol Metab 74,322-331.